Byun, J. M., Dimopoulos, M., Shaikh, E., Gogat-Marchant, K., Green, N. N., Cieri, D., Quach, H. (2025). MagnetisMM-6 part 2: A phase 3, open-label, randomized study of elranatamab in combination with daratumumab and lenalidomide vs daratumumab, lenalidomide, and dexamethasone in transplant-ineligible or -deferred patients with newly diagnosed multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-5845